Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Neurochemistry|September 20, 2006
Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cellsRoya Tehranian, Susana E Montoya, Amber D Van Laar, et al.Journal of Neurochemistry|December 13, 2005
Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell deathArmando P Signore, Zhongfang Weng, Teresa Hastings, et al.Journal of Parkinson'S Disease|August 9, 2021
An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic FunctionAmber D Van Laar, Victor S Van Laar, Waldy San Sebastian, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2008
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in miceLinan Chen, Yunmin Ding, Barbara Cagniard, et al.Frontiers in Neurology|April 23, 2021
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical TrialsAristide Merola, Noelle Kobayashi, Alberto Romagnolo, et al.European Journal of Neurology|August 21, 2012
Phenotypic variability in three families with valosin-containing protein mutationS Spina, A D Van Laar, J R Murrell, et al.Annals of Neurology|February 26, 2019
Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseChadwick W Christine, Krystof S Bankiewicz, Amber D Van Laar, et al.Frontiers in Neurology|April 27, 2018
Outcomes of Interventional-MRI Versus Microelectrode Recording-Guided Subthalamic Deep Brain StimulationPhilip S Lee, Gregory M Weiner, Danielle Corson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 21, 2025
Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's DiseaseAmber D Van Laar, Chadwick W Christine, Nicolás Phielipp, et al.Pageof 2